Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
307280:KOSDAQ
Wonbiogen Co Ltd
₩7,430.00
+6.14%
(+430.00) 1D
May 22, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 307280...
Open
₩7,180
High
₩7,700
Low
₩6,930
Mkt. cap
52.71B
Avg. vol.
66.36K
Volume
125.82K
Dividend
1.88%
Quarterly dividend
₩35
Ex-dividend date
Dec 27, 2024
P/E ratio
7.44
52-wk high
₩8,400
52-wk low
₩1,155
EPS
₩999
Shares outstanding
7.09M
No. of employees
77
News stories
From sources across the web
About Wonbiogen Co Ltd
CEO-
Employees77
Founded2006
Headquarters-
SectorMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.40B
9.22B
9.37B
9.28B
Cost of goods sold
4.06B
4.32B
4.56B
4.65B
Cost of revenue
4.06B
4.32B
4.56B
4.65B
Research and development expenses
166.17M
222.11M
214.66M
220.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.18B
2.17B
2.27B
2.16B
Operating expense
2.40B
2.34B
2.65B
2.52B
Total operating expenses
6.46B
6.66B
7.21B
7.16B
Operating income
1.94B
2.55B
2.17B
2.12B
Other non operating income
-163.55M
56.00M
-32.04M
51.95M
EBT including unusual items
1.75B
2.66B
1.80B
2.28B
EBT excluding unusual items
1.75B
2.72B
2.12B
2.28B
Income tax expense
305.20M
445.32M
256.13M
416.45M
Effective tax rate
17.41%
16.74%
14.22%
18.29%
Other operating expenses
15.75M
10.90M
15.81M
7.64M
Net income
1.60B
2.18B
1.59B
1.67B
Net profit margin
19.11%
23.63%
16.96%
17.99%
Earnings per share
-
-
-
-
Interest and investment income
66.36M
71.70M
67.38M
59.37M
Interest expense
-11.06M
-9.80M
-7.37M
-14.68M
Net interest expenses
55.30M
61.91M
60.02M
44.69M
Depreciation and amortization charges
108.11M
103.79M
109.68M
145.33M
EBITDA
2.31B
2.92B
2.54B
2.52B
Gain or loss from assets sale
-
59.48M
64.99M
1.14M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more